In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint is organizing a consultation to identify vaccine research priorities to facilitate further contributions of vaccines to achieve improved control of the pandemic everywhere.

This is scheduled to take place on Friday, 25 March 2022 from 13h00 to 18h30 Geneva time (CET). During this forthcoming consultation, global experts will review the available evidence, enumerate knowledge gaps, and outline research priorities related to pan-sarbecovirus vaccines. The objectives of the meeting are to:

• Review scientific advances and development approaches to enable the development of a pan-sarbecovirus vaccine.
• Outline novel approaches for evaluation of pan-sarbecovirus vaccines, including in the context of the different variants of concern.
• Discuss how we can prospectively evaluate vaccines intended to protect against viruses that are not yet circulating.